Document is current
Any future updates will be listed below
-
Authors
Desgres, Manon
Poyraz, Melis
Sari, Buse
Duhoux, François P.
van Marcke, Cédric
Corbet, Cyril
-
Funding
Funding for this research was provided by:
Action de Recherche Concertée (ARC23/28-129, ARC23/28-129, ARC23/28-129)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 2 August 2025
First Online: 11 August 2025
Declarations
:
: Not applicable.
: Not applicable.
: FP.D. reports a relationship with Foundation Against Cancer that includes: funding grants. C.vM. reports a relationship with Belgian Society of Medical Oncology vzw that includes: board membership. C.vM. reports a relationship with Eli Lilly and Company, Novartis, AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, and Menarini Laboratories, that includes: consulting or advisory. C.vM. reports a relationship with AstraZeneca Pharmaceuticals LP, Merck & Co Inc, and Menarini Laboratories that includes: speaking and lecture fees. C.vM. reports a relationship with DigiCore and Gilead Sciences Inc that includes: funding grants. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
